MedPath

A Study to compare topical therapy(DPCP) in alopecia areata versus oral steroids

Phase 4
Conditions
Health Condition 1: L639- Alopecia areata, unspecified
Registration Number
CTRI/2018/10/015870
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients with severe non progressive alopecia areata with SALT score more than 40 and age less than 18 years.

Exclusion Criteria

1.Progressive AA- new lesions(more than 5 patches) in last 3 months

2.Patients with severe hepatic, renal or other systemic disorder

3.Patients experiencing spontaneous regrowth of lost hair

4.Patients of known hypersensitivity to DPCP

5.Presence of any contraindication for corticosteroids

6.Parents/Patients not giving consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Change in SALT score from baseline in both the groups. <br/ ><br>2.Cosmetically acceptable hair regrowth or cosmetically unacceptable hair regrowth in both the groups <br/ ><br>Timepoint: o months, 1 month, 2 months, 3 months, 4 months, 5 months, and at 6 months
Secondary Outcome Measures
NameTimeMethod
umber of adverse effects in group A versus group BTimepoint: 24weeks
© Copyright 2025. All Rights Reserved by MedPath